GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 235 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $810,000 | +30.9% | 11,900 | +21.3% | 0.00% | +33.3% |
| Q2 2020 | $619,000 | +66.4% | 9,812 | +34.4% | 0.00% | +50.0% |
| Q1 2020 | $372,000 | -41.4% | 7,300 | -8.8% | 0.00% | -33.3% |
| Q4 2019 | $635,000 | +9.1% | 8,000 | -33.3% | 0.00% | +200.0% |
| Q3 2019 | $582,000 | +78.5% | 12,000 | +93.5% | 0.00% | 0.0% |
| Q2 2019 | $326,000 | +58.3% | 6,200 | +59.0% | 0.00% | 0.0% |
| Q1 2019 | $206,000 | +216.9% | 3,900 | +143.8% | 0.00% | – |
| Q4 2018 | $65,000 | +400.0% | 1,600 | +220.0% | 0.00% | – |
| Q2 2017 | $13,000 | -27.8% | 500 | 0.0% | 0.00% | – |
| Q1 2017 | $18,000 | +157.1% | 500 | 0.0% | 0.00% | – |
| Q4 2016 | $7,000 | -36.4% | 500 | 0.0% | 0.00% | – |
| Q3 2016 | $11,000 | -85.7% | 500 | -89.4% | 0.00% | – |
| Q2 2016 | $77,000 | +126.5% | 4,700 | +113.6% | 0.00% | – |
| Q1 2016 | $34,000 | -52.1% | 2,200 | 0.0% | 0.00% | – |
| Q4 2015 | $71,000 | -22.8% | 2,200 | 0.0% | 0.00% | – |
| Q3 2015 | $92,000 | – | 2,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 595,473 | $25,790,000 | 4.19% |
| Grace Capital | 131,549 | $5,697,000 | 3.60% |
| Fernwood Investment Management, LLC | 201,657 | $8,734,000 | 3.44% |
| Fairmount Funds Management LLC | 215,000 | $9,312,000 | 3.33% |
| Arctis Global LLC | 293,700 | $12,720,000 | 2.74% |
| Perceptive Advisors | 5,674,711 | $245,771,000 | 2.64% |
| ArchPoint Investors | 217,510 | $9,420,000 | 2.61% |
| Alerce Investment Management, L.P. | 126,270 | $5,469,000 | 2.15% |
| Profit Investment Management, LLC | 42,196 | $1,826,000 | 1.17% |
| Affinity Asset Advisors, LLC | 50,000 | $2,166,000 | 1.15% |